Zhejiang Shouxiangu Pharmaceutical Co., Ltd.
SHH: 603896.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Zhen-Yu Li
- Employees
- 1,118
- Headquarters
- Jinhua, China
- IPO year
- 2017
- Market cap
- CN¥3.4B
- Website
- https://www.sxg1909.com
Loading 603896…
Loading profile data…Frequently asked questions about 603896
What does Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS) do?
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. researches, develops, and sells Chinese medicine products. It offers ganoderma lucidum spore powder, dendrobium officinale, crocus sativus, and other health products. The company was founded in 1997 and is based in Jinhua, China.
Where does 603896.SS trade?
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS) trades on the Shanghai Stock Exchange.
What sector is 603896.SS in?
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Zhejiang Shouxiangu Pharmaceutical Co., Ltd.?
Zhen-Yu Li is the chief executive officer of Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS).
Where is Zhejiang Shouxiangu Pharmaceutical Co., Ltd. headquartered?
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. is headquartered in China.
Does 603896.SS pay a dividend?
Yes — Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS) paid a trailing twelve-month dividend of CNY 0.27 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 603896.SS go public?
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS) completed its initial public offering in 2017.